冠状动脉血运重建的长期展望
该文基于历史趋势与近期突破,预测至2040年冠状动脉血运重建的进展。作者曾于2000年预测药物洗脱支架、冠状动脉CT血管造影和生物可吸收支架的影响,现重点讨论人工智能与组学科学。影像组学(影像与组学整合)将成为变革性工具,人工智能助力在药物与机械血运重建之间做出更个性化决策。
要点
- 影像组学结合人工智能可优化药物与机械血运重建的个体化选择。
- 光子计数CT与光纤实时形状传感有望实现低辐射高分辨率成像。
- 年轻患者机械血运重建需求或因斑块消退疗法和新型抗动脉粥样硬化生物制剂而下降。
核心结论
- 未来心肌血运重建将日益个性化,技术驱动的干预将重新定义心血管医学。
研究设计与样本
- 基于历史趋势与近期突破的预测性分析,无原始研究样本。
主要发现
- 影像组学与人工智能将助力药物与机械血运重建的个性化决策。
- 光子计数CT和光纤实时形状传感有望实现低辐射高分辨率成像。
- 机器人技术与3D全息图预期提高经皮和外科血运重建的精确性与结局。
- 年轻患者机械血运重建需求可能因有效斑块消退疗法和新型强效抗动脉粥样硬化生物制剂而下降。
- 老龄化人口将推动机械干预需求,斑块旋切与碎石技术改善复杂钙化病变结局。
临床怎么用
- 关注影像组学与人工智能在血运重建决策中的应用前景。
- 对年轻患者可考虑斑块消退疗法以降低机械血运重建需求。
- 复杂钙化病变可借助斑块旋切与碎石技术改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This paper will forecast advancements in coronary revascularization by 2040, drawing on historical trends and recent breakthroughs. Having forecasted in 2000 the impact of innovations like drug-eluting stents, coronary computed tomography angiography, and bioresorbable scaffolds, the authors examine the evolving landscape of coronary artery disease treatment emphasizing artificial intelligence and omics sciences. Imagenomics-the integration of imaging and omics-will be a transformative tool with artificial intelligence enabling more personalized decisions between pharmacological and mechanical revascularization. The shift towards minimally invasive, image-guided procedures is discussed along with the potential obsolescence of current antiplatelet and anticoagulant therapies with novel biomimetic peptides like CD31-covalently bound to metallic or polymeric devices. Advances in photon-counting computed tomography and Fibre Optic Real Shape promise high-resolution imaging with lower radiation, enhancing procedural safety and diagnostic accuracy. It is anticipated that robotics and 3D holograms in percutaneous and surgical revascularization will improve precision and the resulting outcomes. Additionally, the need for mechanical revascularization for younger patients may decline due to effective plaque regression therapies and novel potent anti-atherogenic biologics. However, the aging population will drive demand for mechanical interventions, with advancements in atherectomy and lithotripsy techniques improving outcomes in complex, calcified lesions. This comprehensive analysis outlines a future where myocardial revascularization becomes increasingly personalized, with technology-driven interventions redefining cardiovascular medicine.
引用
- Serruys PW, Oshima A, Ferraz-Costa G, et al. Coronary revascularization: a long-term perspective. Eur Heart J. 2026. PMID: 41271218. doi:10.1093/eurheartj/ehaf883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。